Gene · 10332
Papers1,514
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,514
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association between single-nucleotide polymorphism rs868875 of CLEC4M gene and clinical severity of COVID-19 in a Brazilian population. | Immunogenetics | 2025 | 41062837 | PubTator, text mining | PubMed |
| CD63-Mediated SARS-CoV-2 RBD Fusion Neoantigen DNA Vaccine Enhances Antitumor Immune Response in a Mouse Panc02 Model via EV-Targeted Delivery. | Vaccines (Basel) | 2025 | 41012180 | PubTator, text mining | PubMed |
| Polyvalent Mannuronic Acid-Coated Gold Nanoparticles for Probing Multivalent Lectin-Glycan Interaction and Blocking Virus Infection. | Viruses | 2025 | 40872780 | PubTator, text mining | PubMed |
| Factors determining the outcomes of immune imprinting after repeated orthoflavivirus infections. | Front Immunol | 2025 | 40740782 | PubTator, text mining | PubMed |
| Engineered Dual-Function Antibody-Like Proteins to Combat SARS-CoV-2-Induced Immune Dysregulation and Inflammation. | Adv Sci (Weinh) | 2025 | 40619617 | PubTator, text mining | PubMed |
| Validation of signature molecular profiles of advanced HCV liver disease in hepatocellular carcinoma patients. | Virus Res | 2025 | 40490198 | PubTator, text mining | PubMed |
| Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis. | Thromb Res | 2025 | 40398046 | PubTator, text mining | PubMed |
| A multiomics approach reveals novel regulators of plasma factor V levels, highlighting CLEC4M as a clearance receptor. | Blood | 2025 | 40359434 | PubTator, text mining | PubMed |
| Lewis-X-Containing Triterpenoid Saponins Inhibit DC-SIGN- and L-SIGN-Mediated Transfer of HIV-1 Infection. | Chemistry | 2025 | 40277287 | PubTator, text mining | PubMed |
| MCP-1 Reduction by L-SIGN Expression in Dengue Virus-Infected Liver Endothelial Cells. | Viruses | 2025 | 40143272 | PubTator, text mining | PubMed |
| Glycan-Silica Nanoparticles as Effective Inhibitors for Blocking Virus Infection. | ACS Appl Mater Interfaces | 2025 | 39908032 | PubTator, text mining | PubMed |
| Plasma Proteomic Signatures of Physical Activity Provide Insights into Biological Impacts of Physical Activity and its Protective Role Against Dementia. | medRxiv | 2025 | 39867359 | PubTator, text mining | PubMed |
| Simultaneous Blockade of CD209 and CD209L by Monoclonal Antibody Does Not Provide Sufficient Protection Against Multiple Viral Infections In Vivo. | Immunology | 2025 | 39783143 | PubTator, text mining | PubMed |
| From viral assembly to host interaction: AFM's contributions to virology. | J Virol | 2025 | 39655953 | PubTator, text mining | PubMed |
| Identification of Hub Genes in Liver Hepatocellular Carcinoma Based on Weighted Gene Co-expression Network Analysis. | Biochem Genet | 2025 | 38683466 | PubTator, text mining | PubMed |
| State of Knowledge About Thyroid Cancers in the Era of COVID-19-A Narrative Review. | Biomedicines | 2024 | 39767735 | PubTator, text mining | PubMed |
| Autoantibodies in hospitalised patients with COVID-19. | Clin Transl Immunology | 2024 | 39734590 | PubTator, text mining | PubMed |
| Unprecedented selectivity for homologous lectin targets: differential targeting of the viral receptors L-SIGN and DC-SIGN. | Chem Sci | 2024 | 39246372 | PubTator, text mining | PubMed |
| Polyvalent Glycomimetic-Gold Nanoparticles Revealing Critical Roles of Glycan Display on Multivalent Lectin-Glycan Interaction Biophysics and Antiviral Properties. | JACS Au | 2024 | 39211605 | PubTator, text mining | PubMed |
| Multi-omics Approach Reveals Influenza-A Virus Target Genes Associated Genomic, Clinical and Immunological Characteristics in Cancers. | Biomed Environ Sci | 2024 | 39198235 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10332/papers?page=2